Peritonitis and Abdominal Sepsis Differential Diagnoses
- Author: Brian James Daley, MD, MBA, FACS, FCCP, CNSC; Chief Editor: Julian Katz, MD more...
Diagnostic Considerations
Thoracic processes with diaphragmatic irritation (eg, empyema), extraperitoneal processes (eg, pyelonephritis, cystitis, acute urinary retention), and abdominal wall processes (eg, infection, rectus hematoma) may mimic certain signs and symptoms of peritonitis. Always examine the patient for the presence of external hernias to rule out intestinal incarceration.
According to Adler and Gasbarra, the following should be considered in the differential diagnosis[8] :
- Chemical irritants (eg, bile, blood, gastric juice, barium, enema or douche contents)
- Chronic peritoneal dialysis
- Chylous peritonitis
- Eosinophilic peritonitis
- Familial Mediterranean fever
- Fungal infections (eg, histoplasmosis, cryptococcosis, coccidioidomycosis)
- Granulomatous peritonitis (eg, parasitic infestations, sarcoidosis, tumors, Crohn disease, starch granules)
- Gynecologic disorders (Chlamydia peritonitis, salpingitis, endometriosis, teratoma, leiomyomatosis, dermoid cyst)
- HIV-associated peritonitis (from opportunistic organisms)
- Mesothelial hyperplasia and metaplasia
- Neoplasms (eg, primary mesothelioma, secondary carcinomatosis, Pseudomyxoma peritonei)
- Parasitic infections (eg, schistosomiasis, ascariasis, enterobiasis, amebiasis, strongyloidiasis)
- Perforated viscus
- Peritoneal encapsulation
- Peritoneal loose bodies and peritoneal cysts
- Peritoneal lymphangiectasis
- Pyelonephritis
- Sclerosing peritonitis
- Splenosis
- Vascular conditions (eg, mesenteric embolus, mesenteric nonocclusive ischemia, ischemic colitis, portal vein thrombosis, mesenteric vein thrombosis)
- Vasculitis (eg, systemic lupus erythematosus, allergic vasculitis [Henoch-Schönlein purpura], Kohlmeier-Degos disease, polyarteritis nodosa)
Differential Diagnoses
- Aneurysm, Abdominal
- Angioedema
- Appendicitis, Acute
- Mesenteric Ischemia
- Urinary Tract Infection in Females
- Whipple Disease
Pavlidis TE. Cellular changes in association with defense mechanisms in intra-abdominal sepsis. Minerva Chir. Dec 2003;58(6):777-81. [Medline].
Appenrodt B, Grünhage F, Gentemann MG, Thyssen L, Sauerbruch T, Lammert F. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology. Apr 2010;51(4):1327-33. [Medline].
Barretti P, Montelli AC, Batalha JE, Caramori JC, Cunha Mde L. The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients. BMC Infect Dis. Dec 22 2009;9:212. [Medline]. [Full Text].
[Guideline] Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. Mar 2004;39(3):841-56. [Medline].
Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World J Gastroenterol. Nov 28 2009;15(44):5505-10. [Medline]. [Full Text].
Bert F, Noussair L, Lambert-Zechovsky N, Valla D. Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Eur J Gastroenterol Hepatol. Sep 2005;17(9):929-33. [Medline].
Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou-Kastellanou C, Archimandritis AJ. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. Feb 2005;25(1):57-61. [Medline].
Adler SN, Gasbarra DB. A Pocket Manual of Differential Diagnosis. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005.
Nouri-Majalan N, Najafi I, Sanadgol H, Ganji MR, Atabak S, Hakemi M, et al. Description of an outbreak of acute sterile peritonitis in Iran. Perit Dial Int. Jan-Feb 2010;30(1):19-22. [Medline].
Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. Apr 2003;37(4):897-901. [Medline].
Cheruvattath R, Balan V. Infections in Patients With End-stage Liver Disease. J Clin Gastroenterol. Apr 2007;41(4):403-11. [Medline].
Soriano G, Castellote J, Alvarez C, et al. Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management. J Hepatol. Jan 2010;52(1):39-44. [Medline].
Marshall JC. Intra-abdominal infections. Microbes Infect. Sep 2004;6(11):1015-25. [Medline].
Riggio O, Angeloni S. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis. World J Gastroenterol. Aug 21 2009;15(31):3845-50. [Medline]. [Full Text].
Gaya DR, David B Lyon T, Clarke J, Jamdar S, Inverarity D, Forrest EH, et al. Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol. Apr 2007;19(4):289-95. [Medline].
Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005;65(12):1611-20. [Medline].
Hawker FH. How to feed patients with sepsis. Curr Opin Crit Care. Aug 2000;6(4):247-252. [Medline].
Runyon B. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Vol 2. 8th ed. Philadelphia, Pa: Saunders; 2006:1935-64.
Colizza S, Rossi S. Antibiotic prophylaxis and treatment of surgical abdominal sepsis. J Chemother. Nov 2001;13 Spec No 1(1):193-201. [Medline].
Ginés P, Rimola A, Planas R, Vargas V, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. Oct. 1990;12(4 Pt 1):716-24.
Soares-Weiser K, Brezis M, Leibovici L. Antibiotics for spontaneous bacterial peritonitis in cirrhotics. Cochrane Database Syst Rev. 2001;CD002232. [Medline].
Tubau F, Liñares J, Rodríguez MD, Cercenado E, Aldea MJ, González-Romo F, et al. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery. Diagn Microbiol Infect Dis. Mar 2010;66(3):308-13. [Medline].
[Best Evidence] Wiggins KJ, Craig JC, Johnson DW, Strippoli GF. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev. Jan 23 2008;CD005284. [Medline].
| Source Regions | Causes |
| Esophagus | Boerhaave syndrome Malignancy Trauma (mostly penetrating) Iatrogenic* |
| Stomach | Peptic ulcer perforation Malignancy (eg, adenocarcinoma, lymphoma, gastrointestinal stromal tumor) Trauma (mostly penetrating) Iatrogenic* |
| Duodenum | Peptic ulcer perforation Trauma (blunt and penetrating) Iatrogenic* |
| Biliary tract | Cholecystitis Stone perforation from gallbladder (ie, gallstone ileus) or common duct Malignancy Choledochal cyst (rare) Trauma (mostly penetrating) Iatrogenic* |
| Pancreas | Pancreatitis (eg, alcohol, drugs, gallstones) Trauma (blunt and penetrating) Iatrogenic* |
| Small bowel | Ischemic bowel Incarcerated hernia (internal and external) Closed loop obstruction Crohn disease Malignancy (rare) Meckel diverticulum Trauma (mostly penetrating) |
| Large bowel and appendix | Ischemic bowel Diverticulitis Malignancy Ulcerative colitis and Crohn disease Appendicitis Colonic volvulus Trauma (mostly penetrating) Iatrogenic |
| Uterus, salpinx, and ovaries | Pelvic inflammatory disease (eg, salpingo-oophoritis, tubo-ovarian abscess, ovarian cyst) Malignancy (rare) Trauma (uncommon) |
| *Iatrogenic trauma to the upper GI tract, including the pancreas and biliary tract and colon, often results from endoscopic procedures; anastomotic dehiscence and inadvertent bowel injury (eg, mechanical, thermal) are common causes of leak in the postoperative period. | |
| Type | Organism | Percentage |
| Aerobic | ||
| Gram negative | Escherichia coli | 60% |
| Enterobacter/Klebsiella | 26% | |
| Proteus | 22% | |
| Pseudomonas | 8% | |
| Gram positive | Streptococci | 28% |
| Enterococci | 17% | |
| Staphylococci | 7% | |
| Anaerobic | Bacteroides | 72% |
| Eubacteria | 24% | |
| Clostridia | 17% | |
| Peptostreptococci | 14% | |
| Peptococci | 11% | |
| Fungi | Candida | 2% |
| Peritonitis (Type) | Etiologic Organisms | Antibiotic Therapy (Suggested) | |
| Class | Type of Organism | ||
| Primary | Gram-negative | E coli (40%) K pneumoniae (7%) Pseudomonas species (5%) Proteus species (5%) Streptococcus species (15%) Staphylococcus species (3%) Anaerobic species (< 5%) | Third-generation cephalosporin |
| Secondary | Gram-negative | E coli Enterobacter species Klebsiella species Proteus species | Second-generation cephalosporin Third-generation cephalosporin Penicillins with anaerobic activity Quinolones with anaerobic activity Quinolone and metronidazole Aminoglycoside and metronidazole |
| Gram-positive | Streptococcus species Enterococcus species | ||
| Anaerobic | Bacteroides fragilis Other Bacteroides species Eubacterium species Clostridium species Anaerobic Streptococcus species | ||
| Tertiary | Gram-negative | Enterobacter species Pseudomonas species Enterococcus species | Second-generation cephalosporin Third-generation cephalosporin Penicillins with anaerobic activity Quinolones with anaerobic activity Quinolone and metronidazole Aminoglycoside and metronidazole Carbapenems Triazoles or amphotericin (considered in fungal etiology) (Alter therapy based on culture results.) |
| Gram-positive | Staphylococcus species | ||
| Fungal | Candida species | ||
| Routine | Optional | Unusual | Less Helpful |
| Cell count | Obtain culture in blood culture (BC) bottles. | Tuberculosis (TB) smear and culture | pH |
| Albumin | Glucose | Cytology | Lactate |
| Total protein | Lactate dehydrogenase (LDH) | Triglyceride | Cholesterol |
| Amylase | Bilirubin | Fibronectin | |
| Gram stain | Alpha 1-antitrypsin | ||
| Glycosaminoglycans |

